Aurobindo Pharma today reported a 4.1 per cent increase in its net profit at Rs 432.4 crore during the first quarter ended June 30, 2015.
The company’s net profit stood at Rs 393.4 crore in the same quarter last fiscal, it said in a statement.
The company’s net sales during the period under review stood at Rs 2,163.14 crore as against Rs 1,934.56 crore in the year-ago period.
“We are pleased to initiate the year with broad based growth across most business verticals,” company’s Managing Director N Govindarajan said in a statement.
Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the company at its meeting held today approved an interim dividend of 50 per cent, that is 50 paise per equity share of Re 1 each for 2015-16.
The interim dividend will be paid on or before September 4. The company said its formulation sales were up by 15.9 per cent to Rs 2,637.1 crore as against Rs 2,275.0 crore in the same period last yearu00b7
API sales too grew by 7.9 per cent to Rs 723 crore.
Company’s shares today closed 2.32 per cent lower at Rs 744.2 apiece on the BSE.